Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for non-localized bronchiectasis.

D Schneiter1, N Meyer, D Lardinois

  • 1Department of Surgery, Division of Thoracic Surgery, University Hospital, Switzerland.

The British Journal of Surgery
|May 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.

Immuno-oncology technology·2025
Same author

The relationship between wearable-derived sleep features and relapse in Major Depressive Disorder.

Journal of affective disorders·2024
Same author

COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study.

Respiratory medicine and research·2024
Same author

Study of the feasibility of outpatient sacrocolpopexy by laparoscopy.

Journal of gynecology obstetrics and human reproduction·2024
Same author

The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.

Annales de dermatologie et de venereologie·2024
Same author

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.

Cancer immunology, immunotherapy : CII·2023
Same journal

Trimester-Specific Safety of Laparoscopic versus Open Abdominal Surgery During Pregnancy: A Systematic Review and Meta-analysis.

The British journal of surgery·2026
Same journal

The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities.

The British journal of surgery·2026
Same journal

Patient-led, home-based follow-up for colorectal cancer: the DISTANCE multicentre stepped-wedge cluster-randomised trial.

The British journal of surgery·2026
Same journal

Correction to: Reduced secretory efficiency in parathyroid carcinoma: diagnostic value of the PTH-to-tumour-volume ratio.

The British journal of surgery·2026
Same journal

Global disparities in hepatocellular carcinoma outcomes: multicentre study.

The British journal of surgery·2026
Same journal

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
See all related articles

Surgical resection for non-localized bronchiectasis is safe and effective. Most patients reported satisfaction with the outcomes, with low complication rates and no 30-day mortality in this study of surgical bronchiectasis treatment.

Area of Science:

  • Thoracic Surgery
  • Pulmonary Medicine

Background:

  • Surgical resection is a standard treatment for localized bronchiectasis.
  • Limited data exists on the efficacy of surgery for non-localized bronchiectasis.

Purpose of the Study:

  • To evaluate the safety and outcomes of surgical resection for patients with non-localized bronchiectasis.
  • To compare outcomes between localized and non-localized bronchiectasis treatment groups.

Main Methods:

  • Retrospective review of 55 patients without cystic fibrosis undergoing resection between 1992 and 2001.
  • 48 patients were followed long-term, divided into localized (Group 1, n=25) and non-localized (Group 2, n=23) disease.
  • Video Assisted Thoracoscopic Surgery (VATS) was used in 31 patients.

Main Results:

Related Experiment Videos

  • No 30-day mortality observed.
  • Mean hospital stay was similar for both groups (10.9 days Group 1, 11.1 days Group 2).
  • High patient satisfaction reported at 6 months (23/25 in Group 1, 16/23 in Group 2); low rates of recurrent infection and hemoptysis.

Conclusions:

  • Surgical treatment for selected patients with non-localized bronchiectasis is safe.
  • Most patients experienced positive outcomes and satisfaction following surgery for non-localized bronchiectasis.